Results for "HDA Factbook"
Chip Davis: Distributors are “Answering the Call” In Response to COVID-19
During one of the most ambitious immunization campaigns in our history, HDA President and CEO Chip Davis reinforced the distribution industry’s commitment to “answering the call” when assisting the federal, state and local governments as part of a nationwide vaccination push.
A Dialogue on COVID-19 and the Future of the Healthcare Supply Chain
HDA recently sponsored and participated in the Milken Institute’s 2021 Future of Health Summit. This year’s event, held on June 22–23, brought together industry experts, public health leaders and elected officials for insightful policy discussions on a variety of issues that are shaping healthcare in our country.
FDA, Industry Experts Urge DSCSA Action at HDA’s 2023 Traceability Seminar
HDA convened more than 400 healthcare supply chain stakeholders, technology experts and regulatory officials for the association’s Traceability Seminar. This highly anticipated event provided a forum to discuss implementation challenges and strategies for Drug Supply Chain Security Act (DSCSA) compliance as the industry faced a November 27, 2023, deadline to establish a framework to trace pharmaceuticals across the supply chain.
Distributors Rising to the Challenge During the Coronavirus Pandemic
As the impact of COVID-19 “coronavirus” pandemic continues to unfold, we are all deeply concerned about our personal health and well-being — and that of our loved ones. As Americans worry about when their workplaces or schools will reopen, or if they have an adequate supply of necessary household staples, many also have heightened concerns about whether they will be able to access the vital medications and healthcare products they rely on each day.